26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS
JACC · 2026-04 · 87 (13) · A287
DOI: 10.1016/j.jacc.2026.02.710 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Abdul-Rahaman Adedolapo Ottun und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ottun, A. A., Okorigba, E. M., Chinnatambi, C. S., Otchere, B., Njobe, B., Pimentel, J., & Kanjo, W. (2026). 26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS. JACC, 87(13), A287. https://doi.org/10.1016/j.jacc.2026.02.710
Vancouver
Ottun AA, Okorigba EM, Chinnatambi CS, Otchere B, Njobe B, Pimentel J, et al. 26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS. JACC. 2026;87(13):A287. doi:10.1016/j.jacc.2026.02.710
BibTeX
@article{Ottun2026,
author = {Ottun, Abdul-Rahaman Adedolapo and Okorigba, Efeturi Maxwell and Chinnatambi, Christopher S. and Otchere, Baffour and Njobe, Brice and Pimentel, Jorge and Kanjo, Wael},
title = {26-A-21088-ACC COMPARATIVE EFFICACY OF PCSK9 INHIBITORS VS BEMPEDOIC ACID AMONG PATIENTS WITH ASCVD WITHOUT DIABETES : A REAL WORLD ANALYSIS},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A287},
doi = {10.1016/j.jacc.2026.02.710}
}
EUVIMED